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The alkaline pH-activated, two-pore domain K+ channel K2P5.1 (also known as
TASK2/KCNK5) plays an important role in maintaining the resting membrane potential,
and contributes to the control of Ca2+ signaling in several types of cells. Recent
studies highlighted the potential role of the K +2P5.1 K channel in the pathogenesis
of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The aim
of the present study was to elucidate the pathological significance of the K2P5.1 K
+
channel in inflammatory bowel disease (IBD). The degrees of colitis, colonic epithelial
damage, and colonic inflammation were quantified in the dextran sulfate sodium-induced
mouse IBD model by macroscopic and histological scoring systems. The expression and
functional activity of K2P5.1 in splenic CD4
+ T cells were measured using real-time PCR,
Western blot, and fluorescence imaging assays. A significant increase was observed in
the expression of K2P5.1 in the splenic CD4
+ T cells of the IBD model. Concomitant with
this increase, the hyperpolarization response induced by extracellular alkaline pH was
significantly larger in the IBD model with the corresponding intracellular Ca2+ rises. The
expression of K2P5.1 was higher in CD4
+CD25− T cells than in CD4+CD25+ regulatory
T cells. The knockout of K2P5.1 in mice significantly suppressed the disease responses
implicated in the IBD model. Alternations in intracellular Ca2+ signaling following the
dysregulated expression of K2P5.1 were associated with the disease pathogenesis of
IBD. The results of the present study suggest that the K +2P5.1 K channel in CD4
+CD25−
T cell subset is a potential therapeutic target and biomarker for IBD.
Keywords: background K+ channel, K2P5.1, CD4
+ T cell, inflammatory bowel disease, Ca2+ influx, cytokine
production
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INTRODUCTION
Due to the overlap in the pathogeneses and pharmacological
treatments, Crohn’s disease (CD) and ulcerative colitis (UC) are
types of inflammatory bowel diseases (IBD) (Bouma and Strober,
2003; McCole, 2014). Dextran sulfate sodium (DSS) is known to
chemically induce the pathogenesis of CD and UC in rodents
(Okayasu et al., 1990; Dieleman et al., 1994). A genome-wide
expression profiling study showed that DSS-associated genes in
mice correlated with data obtained from IBD patients (Fang et al.,
2011). Therefore, the DSS-induced IBD model is a commonly
used model of IBD in mice, and a number of studies have used
the DSS-induced IBD model to investigate the pathogenesis of
CD and UC.
An elevation in intracellular Ca2+ by the release of Ca2+ from
intracellular Ca2+ stores and Ca2+ influx through store-operated
Ca2+ channels is one of the essential triggering signals for T
cell activation (Cahalan and Chandy, 2009; Hogan et al., 2010).
The K+ channel is also one of the key molecules that modulates
Ca2+ signaling in T cells because it provides an electrochemical
gradient to drive Ca2+ influx, and two major K+ channels
(the voltage-gated, KV1.3 and intermediate-conductance Ca
2+-
activated, KCa3.1) function in T and B lymphocytes (Cahalan
and Chandy, 2009). Recent studies including our previous study
demonstrated that the upregulation of ion channels (Orai/STIM,
TRPV1, TRPA1, and KCa3.1) in CD4
+ T cells was involved in
the pathogenesis of IBD, while their pharmacological blockade
elicited a significant decrease in IBD disease severity (Di Sabatino
et al., 2009; Di et al., 2010; Bertin et al., 2014; Kun et al., 2014;
Ohya et al., 2014).
The background or leak two-pore domain K+ (K2P) channel
superfamily includes 16 members and plays a crucial role in
diverse physiological functions through the regulation of cell
excitability (Enyedi and Czirják, 2010; Es-Salah-Lamoureux et al.,
2010). The K2P5.1 K
+ channel (also known as TASK2/KCNK5)
is activated by extra- and intracellular alkalization, and plays
an important role in maintaining the resting membrane
potential and the control of Ca2+ signaling in various
types of cells. K2P5.1 has been shown to control diverse
physiological and pathophysiological processes including innate
immunity and cancer progression (Bittner et al., 2010b; Clark
et al., 2011; Cid et al., 2013), and is, therefore, expected
to become a potential therapeutic target for the treatment
Abbreviations: K2P, two-pore domain K
+ (channel); TASK, TWIK-related
acid-sensitive K+ (channel); TWIK, tandem of P-domains in a weakly inward
rectifying K+ (channel); TALK, TWIK-related alkaline pH-activated K+
(channel); IBD, inflammatory bowel disease; DSS, dextran sodium sulfate;
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; DiBAC4(3), bis-
(1,3-dibutylbarbituric acid)trimethine oxonol; Fura 2-AM, acetoxymethyl 2-[5-
[bis[(acetoxymethoxy-oxo-methyl)methyl]amino]-4-[2-[2-[bis[(acetoxymethoxy-
oxo-methyl)methyl]amino]-5-methyl-phenoxy]ethoxy]benzofuran-2-yl]oxazole-
5-carboxylate; FCM, flow cytometry; IFN, interferon; IL, interleukin; pHe,
extracellular pH; CD, cluster of differentiation or Crohn’s disease; UC,
ulcerative colitis; FITC, fluorescein isothiocyanate; PE, Phycoerythrin; 2-APB, 2-
aminoethoxydiphenyl borate; Orai, Ca2+ release-activated Ca2+ (channel); STIM,
stromal interaction molecule; TRPV, transient receptor potential, vanilloid; TRPA,
transient receptor potential, subfamily A; KCa, Ca
2+-activated K+ (channel); KV ,
voltage-gated K+ (channel).
of autoimmune, inflammatory, and allergic diseases as well
as several types of cancers. Recent studies described the
pathophysiological impact of the upregulation of K2P5.1 in
CD4+ and CD8+ T cells on the pathogenesis of autoimmune
diseases such as rheumatoid arthritis and multiple sclerosis
(Bittner et al., 2010a, 2011). K2P5.1 is inhibited by non-
selective K+ channel inhibitors such as quinidine, lidocaine,
and clofilium and is activated by volatile anesthetics (Wulff
and Zhorov, 2008); however, the lack of selective blockers
is represents an important difficulty in experimental studies
on K2P5.1.
In the present study, we examined the involvement of the
K2P5.1 K
+ channel in CD4+ T lymphocytes in the pathogenesis
of IBD using a mouse model of chemically-induced IBD. We
further compared histopathologies between the DSS-induced
IBD model using wild-type and K2P5.1-deficient mice.
MATERIALS AND METHODS
Preparation of the Dextran Sulfate Sodium
(DSS)-induced Mouse IBD Model
Male C57BL/6J (6–7 weeks of age) mice were purchased
from Shimizu Laboratory Supplies (Kyoto, Japan), and were
acclimatized for 1 week before the experiment. They were
given distilled water containing 5.0% (wt/vol) dextran sulfate
sodium 5000 (DSS) (Wako Pure Chemical, Osaka, Japan) ad
libitum. Control mice were given drinking water only. Seven
days after the administration of DSS, mice were sacrificed,
tissue samples were taken, and colitis and inflammation were
assessed macroscopically and scored as previously reported
(Ohya et al., 2014). All experiments were carried out in
accordance with the guiding principles for the care and use
of laboratory animals in Kyoto Pharmaceutical University,
and the protocols were approved by the committee on the
Ethics of Animal Research of Kyoto Pharmaceutical University
(Permit Number: 15-12-091). K2P5.1 heterozygous knockout
mice bred in a C57BL6 background [B6;CB-Kcnk5Gt(pU-
21)81Imeg] were established by the exchangeable gene trap
method (Araki et al., 2014). Homozygous (K2P5.1
−/−) knockout
mice were generated by crossing heterozygous (K2P5.1
+/−)
males with K2P5.1
+/− females (Cid et al., 2013). Genomic
DNA was isolated from finger or tail biopsies following a
3-h digestion at 50◦C in buffer containing 50mM Tris-HCl
(pH 8.0), 100mM EDTA, 100mM NaCl, 0.1% SDS, and
1mg/mL proteinase K, followed by heat inactivation. PCR was
performed using the primer pairs to distinguish the K2P5.1
wild type (forward: 5′-GCTGAGAACAATAGGGACAG-3′
and reverse: 5′-TCACCCAGCTTTGGGATTCC-3′) and gene
trapped (forward: 5′-GCTGAGAACAATAGGGACAG-3′and
reverse: 5′-TACAGGCATCGTGGTGTCAC-3′). PCR conditions
were as follows: 30 cycles at 94◦C for 30 s, 60◦C for 30 s, and
68◦C for 30 s. The amplified products were separated on 1.0%
agarose gels, and visualized by ethidium bromide staining.
DSS-induced IBD model mice were prepared using male and
female K2P5.1
−/− (6–10 weeks of age) and K2P5.1
+/− (6 weeks
of age) mice.
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Histological Scoring
Inflammation and crypt damage in hematoxylin and eosin
(H&E)-stained sections were assessed as reported previously
(Dieleman et al., 1994; Ohya et al., 2014). Briefly, for histological
assessments, 1 cm of tissue collected from the distal colon
was fixed in 10% buffered formalin, embedded in a paraffin
block, cut into 5-µm-thick sections, and stained with H&E. The
inflammation score was determined as a multiplication of the
severity grade of inflammation (grade 0, none; grade 1, slight;
grade 2, moderate; grade 3, severe) as well as its extent (grade
0, none; grade 1, mucosa; grade 2, mucosa, and submucosa;
grade 3, transmural). The crypt damage score was determined
as a multiplication of the damage grade of the crypt (grade 0,
none; grade 1, basal 1/3 damage; grade 2, basal 2/3 damage;
grade 3 only the surface epithelium intact; grade 4, entire crypt,
and epithelium lost) and the percent area score (grade 1, 1–
25%; grade 2, 25–50%; grade 3, 51–75%; grade 4, 76–100%). Data
were obtained from three sections of the colon measured at least
200µm apart per animal from four individual mice per group.
Cell Isolation, RNA Extraction, Reverse
Transcription, and Real-time PCR
Total RNA was extracted and reverse transcribed from the T
cells of mouse tissues (Ohya et al., 2013, 2014). Single cell
suspensions were prepared by pressing the spleen (also the
thymus and mesenteric lymph nodes) with a frosted grass slide
and then filtering through a nylon mesh. CD4+ cells were
isolated from cell suspensions by Dynabeads R© FlowComp™
Mouse CD4+ (Invitrogen, Grand Island, NY, USA), according
to the experimental manual supplied by Invitrogen, and were
then collected in phosphate buffered saline (PBS) supplemented
with 0.1% bovine serum albumin. A flow cytometric analysis
confirmed that more than 95% of the purified T cells were
CD4+. CD4+CD25− and CD4+CD25+ cells were also isolated
from cell suspensions by Dynabeads R© FlowComp™ Mouse
CD4+ CD25+ Treg Cells (Invitrogen). A flow cytometric
analysis confirmed that more than 90% of purified T cells were
CD4+CD25− and CD4+CD25+. The resulting cDNA products
were amplified with gene-specific primers, and primers were
designated using Primer Express™ software (Ver 1.5, Applied
Biosystems, Foster City, CA, USA). Quantitative, real time PCR
was performed using Syber Green chemistry (SYBR R© Premix Ex
Taq™ II) (TaKaRa BIO, Osaka, Japan) on an ABI 7500 sequence
detector system (Applied Biosystems) as previously reported
(Ohya et al., 2014). The following PCR primers for mouse
clones were used for real-time PCR: K2P5.1 (GenBank accession
number: NM_021542, 722-844), amplicon = 123 bp; K2P3.1
(AF065162, 692-812), 121 bp; K2P9.1 (NM_001033876, 757-
877), 121 bp; K2P16.1 (NM_029006, 191-312), 122 bp; interferon
(IFN)-γ (NM_008337, 222-323), 102 bp; interleukin-4 (IL-
4) (NM_021283, 126-246), 121 bp; IL-10 (NM_010548, 245-
355), 111 bp; CD25 (NM_008367, 522-642), 121 bp; IL-17A
(NM_010552, 165-277), 113 bp; β-actin (ACTB) (NM_031144,
419-519), 101 bp. Regression analyses of the mean values of
three multiplex RT-PCRs for log10 diluted cDNA were used
to generate standard curves (Ohya et al., 2014). Unknown
quantities relative to the standard curve for a particular set of
primers were calculated, yielding the transcriptional quantitation
of gene products relative to the endogenous standard, ACTB. The
following PCR primers were used for real-time PCR to confirm
the knockout of K2P5.1 transcripts in T cells from K2P5.1
−/−
mice: K2P5.1 (NM_021542, 472-567), 96 bp.
Western Blotting
Splenic CD4+ T cells were solubilized with lysis buffer with
1% SDS. The same amount of proteins (10µg for each) were
subjected to 10% SDS-PAGE (Ohya et al., 2014). The blots
were incubated with an anti-K2P5.1 antibody (G-14 or H-170,
Santa Cruz Biotechnology, Santa Cruz, CA, USA), and then
incubated with anti-rabbit or anti-goat horseradish peroxidase-
conjugated IgG (Millipore). An enhanced chemiluminescence
detection system (GE Healthcare, Buckinghamshire, England)
was used to detect the bound antibody. The resulting images were
analyzed by a LAS-3000mini device (Fujifilm, Tokyo, Japan). The
blots were also probed with an anti-β-actin (ACTB) antibody
(Medical & Biological Laboratories, Nagoya, Japan).
Measurement of the Membrane Potential
and Intracellular Ca2+ Concentrations by
Fluorescent Indicators
The membrane potential was measured using the fluorescent
voltage-sensitive dye DiBAC4(3), as previously reported (Ohya
et al., 2013, 2014). Glass bottom tissue culture dishes were
coated with fibronectin (Wako Pure Chemical Industries, Osaka,
Japan) in Ca2+ and Mg2+-free PBS at 50µg/mL for 1µg/cm2 at
4◦C overnight. Cells were seeded onto fibronectin-coated dishes
and cultured for 2 h at 37◦C in 5% CO2 humidified incubator.
Prior to the fluorescence measurements with DiBAC4(3), cells
were incubated in normal HEPES buffer containing 100 nM
DiBAC4(3) for 20min at room temperature. The cells were
continuously incubated with 100 nM DiBAC4(3) throughout
the experiments. In membrane potential imaging, cells loaded
with DiBAC4(3) were illuminated at a wavelength of 490 nm,
and fluorescence images were recorded on the ORCA-Flash2.8
digital camera (Hamamatsu Photonics, Hamamatsu, Japan).
Additionally, intracellular Ca2+ concentrations were measured
using the fluorescent Ca2+ indicator dye Fura 2-AM. Cells were
incubated with 10µM Fura 2-AM in normal HEPES solution for
30min at room temperature. Cells loaded with Fura 2-AM were
alternatively illuminated at wavelengths of 340 and 380 nm, and
fluorescence images were recorded. The fluorescent intensity of
Fura 2 was expressed as measured 340/380 nm fluorescence ratios
after background subtraction. Data collection and analyses were
performed using an HCImage system (Hamamatsu Photonics).
Images were measured every 5 s, and the values of fluorescent
intensity (F) were determined bymeasuring the average for 1min
(12 images).
Flow Cytometric Analysis
Cell surface markers were analyzed with BD FACSCalibur (BD
Biosciences, San Jose, CA, USA), which acquired at least 10,000
events, and gated according to forward- and side-scatter (Ohya
et al., 2013). Data were analyzed using CellQuest software (BD
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FIGURE 1 | Expression levels of K2P5.1 and pro-inflammatory
cytokines in splenic CD4+ T lymphocytes of chemically-induced IBD
model mice. (A) spleen weight relative to body weight in control and IBD
mice. (B–D) quantitative, real-time PCR assay for the expression of IFN-γ (B),
IL-17A (C), and K2P5.1 (D) transcripts in the splenic CD4
+ cells of control and
IBD model mice. Expression levels are expressed as a ratio to β-actin (ACTB).
(E) splenic CD4+ cell lysates were probed by immunoblotting with an
anti-K2P5.1 (G-14) antibody. Molecular weight standards are shown in
kilodaltons (kDa) on the right. Arrowheads indicate the migrating positions of
K2P5.1 and ACTB proteins (open: K2P5.1, closed: glycosylated K2P5.1, gray:
ACTB). Lower panel shows signals after the pre-incubation of a primary
antibody with excess antigens. (F) summarized data obtained from (E) as the
optical density of the band signal for K2P5.1 (open arrowhead) in the IBD
model relative to that in normal mice. (G) Expression of alkaline pH-activated
K2P K
+ channel subtype (K2P3.1, 9.1, and 16.1) transcripts in the splenic
CD4+ T cells of control and IBD model mice. (H) the percentages of the
CD4+ T cell population relative to CD3+ T cells were analyzed by flow
cytometry, acquiring at least 10,000 events. Results were expressed as means
± SEM. Numbers used for the experiments are shown in parentheses. *,
**P < 0.05, 0.01 vs. control mice (ctrl).
Biosciences). The lymphocyte gate was established by analyzing
the forward angle vs. right angle light scatter. The percentage
of positive-staining cells was determined by comparing the
test histograms with those obtained using a fluorescein
isothiocyanate (FITC) or phycoerythrin (PE)-conjugated anti-
CD4 antibody (FITC/PE-CD4), FITC-conjugated CD3 (FITC-
CD3), PE-conjugated CD8 (PE-CD8), and PE-conjugated CD25
(PE-CD25) (BD Biosciences). After being incubated with the
antibodies for 1 h at room temperature, excess antibodies were
removed by repeated washing with PBS.
Chemicals
The sources of pharmacological agents were as follows: clofilium
tosylate (Sigma-Aldrich, Tokyo, Japan), DiBAC4(3), (Dojindo,
Kumamoto, Japan), Fura 2-AM (Invitrogen), and 2-APB (Tocris
Bioscience, Ellisville, MO, USA). All others were obtained from
Sigma-Aldrich or Wako Pure Chemical Industries.
Statistical Analysis
Significant differences between two and among multiple groups
were evaluated using the Student’s t- and Welch’s t-tests or
Tukey’s test after the F-test or ANOVA. Data that were non-
normal distributed were analyzed using the Mann-Whitney U-
test. Significance at P < 0.05 and P < 0.01 was indicated in the
figures. Data are presented as means± SE.
RESULTS
Upregulated Expression of the K2P5.1 K
+
Channel in Splenic CD4+ T Cells from the
Mouse Model of DSS-induced
Inflammatory Bowel Disease
Mice were sacrificed 7 days after the administration of 5.0%
(wt/vol) DSS and tissue samples were collected. Control mice
were given drinking water only. As previously reported (Ohya
et al., 2014), severe macroscopic symptoms (colitis and fecal
blood) were detected in DSS-induced IBD model mice, and
the scores of colonic inflammation and crypt damage were
significantly higher in IBD model mice than in control mice
(not shown). As reported by Pereira et al. (1987), enlargement
of the spleen, “splenomegaly,” was detected in IBD model mice
(Figure 1A), and a significant increase in the transcriptional
expression of the Th1 cytokine interferon-γ (IFN-γ) and Th17
cytokine interleukin-17 (IL-17) was detected (Figures 1B,C),
without any changes in the Th2 cytokine IL-4 (not shown). The
flow cytometric analysis showed no significant differences of the
CD4+ phenotypic ratio between isolated splenic CD3+ T cells
from both groups (Figure 1H).
The quantitative, real-time PCR assay showed that the
expression level of the K2P5.1 transcripts was significantly higher
in the splenic CD4+ T cells of IBD model mice (IBD) than in
control mice (ctrl) (Figure 1D). The expression levels of K2P5.1
relative to ACTB (in arbitrary units) were 0.0036 ± 0.0002 and
0.0161 ± 0.0025 in the splenic CD4+ T cells of control mice
(n = 8) and IBDmodel mice (n = 6, P < 0.01), respectively. The
western blot examination showed that the amount of the K2P5.1
protein (∼50 kDa) in the cell lysate of splenic CD4+ T cells was
higher in IBDmodel mice than in control mice (Figure 1E, upper
panel, open arrowhead), which was consistent with the results
obtained by real-time PCR examination. The amount of the
glycosylated K2P5.1 protein (∼65 kDa, Figure 1E, upper panel,
closed arrowhead) was also higher in the IBD model. The optical
density for the K2P5.1 protein band signal (∼50 kDa) relative to
that for ACTB (Figure 1E, middle panel) was calculated using
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Image J software (Ver. 1.42, NIH), and its protein expression
level in control mice was expressed as 1.00. The relative optical
density in the IBD model was 5.05 ± 0.48 (n = 5 for each,
P < 0.01) (Figure 1F). The two band signals specific for an anti-
K2P5.1 antibody (G-14) disappeared with a pre-incubation with
excess antigens (Figure 1E, lower panel). Similar results were
obtained when another anti-K2P5.1 antibody (H-170) was used as
the primary antibody (Supplementary Figure 1). In addition, the
expression levels of the other alkaline pH-activated K2P channel
subtypes, K2P3.1/TASK1, K2P9.1/TASK3, and K2P16.1/TALK1
transcripts, were less abundant in the IBD model: <0.004 in
arbitrary units (Figure 1G).
Enhancement in Alkaline pHe-induced
Hyperpolarizing Responses in Splenic
CD4+ T Cells of IBD Model Mice
To perform functional analysis of K2P5.1 in splenic CD4
+ T
cells, we measured the hyperpolarizing responses induced by
the alkalization of extracellular pH (pHe) (pHe8.0 and 8.5)
using the membrane potential-sensitive dye, DiBAC4(3). To
confirm living cells, 140mM high K+-induced depolarization
was measured at the end of protocol. As shown in Figure 2A,
the fluorescence intensity of DiBAC4(3) decreased with the
application of alkaline pHe (pHe8.5). The peak amplitude of
the relative fluorescence intensity of DiBAC4(3) was lower
in IBD model mice than in control mice (Figure 2B). When
alkaline pHe-induced hyperpolarizing responses (pHe8.0 and
8.5) were expressed as changes in the relative fluorescence
intensity of DiBAC4(3) [1 relative fluorescence intensity of
DiBAC4(3)], they were significantly larger in IBD model mice
than in control mice (Figure 2C). Under alkaline pHe conditions,
high K+-induced increases in the fluorescence intensity of
DiBAC4(3) were almost the same as those under normal pHe
(pHe7.4) conditions (Figure 2B). In the presence of the non-
specific K2P5.1 blocker, clofilium (5µM), alkaline pHe (pHe8.5)-
induced hyperpolarizing responses disappeared in both groups.
Significantly larger depolarizing responses were observed in IBD
model mice (Figure 2D), suggesting that alkaline pHe-induced
hyperpolarizing responses via the activation of K2P5.1 in IBD
model mice were underestimated. Clofilium also inhibits voltage-
gated K+ channel KV1.3, one of main K
+ channels in T cells,
however, 4-aminopyridine (5mM), a KV1.3 blocker, did not
induce any significant differences in the alkaline pHe (pHe
8.5)-induced hyperpolarizing responses [1 relative fluorescence
intensity of DiBAC4(3)=−0.17± 0.04 (n = 19)]. A recent study
demonstrated that the Ca2+-release activated Ca2+ (CRAC)
channel, Orai1, which contributes to the store-operated entry
of Ca2+ into T cells, was activated by alkaline pH (Beck et al.,
2014), suggesting that the function of Orai1 was upregulated
in the splenic CD4+ T cells of IBD model mice. However,
depolarizing responses were not suppressed by the pre-treatment
with the Orai1 blocker 2-APB (10µM) for more than 5min
(P < 0.01) (Figure 2D), and the expression levels of Orai1
transcripts were also not changed between the two groups
(not shown). We subsequently observed a relationship between
alkaline pHe-induced hyperpolarization responses and [Ca
2+]i
rises via CRAC channels in the splenic CD4+ T cells of IBD
model mice by simultaneously measuring DiBAC4(3) and Fura
2 signals (Figure 2E). As shown in Figure 2F, alkaline pHe-
induced hyperpolarization responses positively correlated with
[Ca2+]i rises in the splenic CD4
+ T cells of IBDmodel mice (R2=
0.41). The alkaline pHe-induced [Ca
2+]i rises were suppressed
by about 40% by the pre-treatment with 2-APB (10µM) (not
shown).
FIGURE 2 | Effects of alkaline pHe on membrane potential and
intracellular Ca2+ mobilization in splenic CD4+ T lymphocytes of IBD
model mice. (A,B) measurement of alkaline pHe (pHe 8.5)-induced
hyperpolarizing responses in splenic CD4+ T cells using the voltage-sensitive
fluorescent dye DiBAC4(3). Images (A) are shown in pseudo-colors from blue
(low intensity) to red (high intensity) in the bar. (B) shows the time course of
changes in the fluorescence intensity of DiBAC4(3). The fluorescence intensity
of DiBAC4(3) at 0 s (pHe 7.4) is expressed as 1.0. (C) summarized data are
shown as alkaline pHe (pHe 8.0 and 8.5)-induced fluorescence changes
[1relative fluorescence intensity of DiBAC4(3)] in splenic CD4
+ T cells of
control and IBD model mice. (D) effects of clofilium (5µM) and the
combination of clofilium (5µM) and 2-APB (10µM) on alkaline-pHe (pHe
8.5)-induced hyperpolarizing responses in the splenic CD4+ T cells of control
and IBD model mice. Cells were pre-treated with clofilium and/or 2-APB for
30min. (E,F) simultaneous measurements of changes in the membrane
potential and intracellular Ca2+ concentrations by hyperpolarizing (pHe 8.5)
and depolarizing (140mM KCl) stimulations using DiBAC4(3) and Fura 2, a
Ca2+ indicator. (E) shows the time course of changes in their fluorescence
intensities, and summarizing data are shown in (F). Results were expressed as
means ± SEM. Numbers used for the experiments are shown in parentheses.
*, **P < 0.05, 0.01 vs. control mice (ctrl).
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Higher Expression Level of K2P5.1 in the
Inflammatory CD4+CD25− Subset than in
the Regulatory CD4+CD25+ Subset
When K2P5.1 is upregulated in Th1/Th17 cells producing IFN-
γ/IL-17, the inhibition of K2P5.1 may suppress the disease
progression of IBD. However, when K2P5.1 is upregulated in
regulatory T cells producing IL-10, the inhibition of K2P5.1 may
promote the disease progression of IBD. In order to clarify
the pathophysiological significance of the K2P5.1 K
+ channel
in IBD, we examined differences in the expression levels of
K2P5.1 between the splenic CD4
+CD25− and CD4+CD25+
subsets in IBD model mice using a real-time PCR assay. As
shown in Figure 3, the proinflammatory Th1/Th17 cytokines
IFN-γ (Figure 3B) and IL-17A (Figure 3C) transcripts were
expressed at high levels in the CD4+CD25− subset of IBD
model mice, whereas the natural regulatory T cell (Treg) markers
CD25 (Figure 3D), IL-10 (Figure 3E), and Foxp3 (not shown)
were predominantly expressed in the CD4+CD25+ subset.
As shown in Figure 3A, K2P5.1 transcripts were expressed at
significantly higher levels in the CD4+CD25− subset in IBD
model mice than in control mice. Significant increases in the
expression levels of the K2P5.1 transcripts were also found in the
CD4+CD25+ subset of IBD model mice (P<0.01 vs. control)
(Figure 3A); however, these increases were significantly lower
than those observed in the CD4+CD25− subset of IBD model
mice (P < 0.01). Correspondingly, similar levels of alkaline
pHe-induced hyperpolarizing responses (pHe8.5) were observed
in the CD4+CD25− subset of IBD model mice but not in the
CD4+CD25+ subset (not shown). These results suggested that
the pharmacological inhibition of K2P5.1 is an effective strategy
for the treatment of IBD.
Decreased Susceptibility to the
Pathogenesis of IBD in K2P5.1 Knockout
Mice
As described above, the lack of selective pharmacological agents
represents the main difficulty in carrying out experimental
studies on K2P5.1. Therefore, we examined the effects of the
genetic inhibition of K2P5.1 on inflammatory responses during
acute IBD in K2P5.1 homozygous knockout (K2P5.1
−/−) mice.
As reported in our recent study (Ohya et al., 2014), severe clinical
symptoms and enlargement of the spleen were observed in wild-
type K2P5.1
+/+ mice (Figures 4A–C, left columns). A significant
protective effect against IBD was observed in K2P5.1
−/− mice
(Figures 4A,B, right columns). The diarrhea scores were 2.25
± 0.16 (n = 8) and 1.41 ± 0.17 (n = 17) in K2P5.1
+/+
and K2P5.1
−/− mice, respectively (P < 0.01 vs. K2P5.1
+/+).
The degrees of splenomegaly was also significantly lower in
K2P5.1
−/− mice (P < 0.05 vs. K2P5.1
+/+). Furthermore,
colonic inflammation and crypt damage were quantified by colon
weight/length ratio measurements and histological scoring. As
shown in Figure 4D, colonic wall thickening was significantly
increased in K2P5.1
+/+ mice, whereas no significant differences
between control and IBD were observed in K2P5.1
−/− mice.
Histological assessments of colonic inflammation and crypt
damage also revealed that both scores were significantly lower
FIGURE 3 | Expression levels of K2P5.1 and pro- and anti-inflammatory
cytokine transcripts in splenic CD4+CD25− and CD4+CD25+ subsets
of IBD model mice. (A–E) real-time PCR assay for the expression of K2P5.1
(A), IFN-γ (B), IL-17A (C), CD25 (D), and IL-10 (E) transcripts in the splenic
CD4+CD25− and CD4+CD25+ T cells of control and IBD model mice.
Results were expressed as means ± SEM. Numbers used for the experiments
are shown in parentheses. **P < 0.01 vs. control mice (ctrl), ##P < 0.01 vs.
the CD4+CD25− subset.
in K2P5.1
−/− mice than in K2P5.1
+/+ mice (P < 0.01 for
the inflammation score, P < 0.05 for the crypt damage score)
(Figures 4E–G). No significant differences in the degrees of
colitis, colonic inflammation, or crypt damage were observed in
heterozygous knockout mice (K2P5.1
+/−) [diarrhea score: 1.95
± 0.20 (n = 22), visible fecal blood score: 2.32 ± 0.17 (n =
22), inflammation score: 10.43 ± 0.87 (n = 7), crypt damage
score: 9.86 ± 0.86 (n = 7)]. In K2P5.1
−/− and K2P5.1
+/− mice
drinking water only for 7 days, all scores assessed in this study
were 0 (not shown). In addition, in the splenic CD4+CD25− and
CD4+CD25+ cells of K2P5.1
−/− mice, the expression level of
K2P5.1 transcripts almost disappeared (Figure 4H), and alkaline
pHe (pHe8.5)-induced hyperpolarizing responses were also very
small in the splenic CD4+ T cells of K2P5.1
−/− mice (Figure 4I).
These results suggest that K2P5.1 inhibitors may be efficacious in
patients with IBD.
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FIGURE 4 | Macroscopic disease activities and histopathological assessments in the IBD model from wild-type (+/+) and homozygous K2P5.1
knockout (-/-) mice. (A,B) Seven days after DSS exposure, diarrhea, and visible fecal blood severities were scored on a 0–3 scale (0, Normal pellets; 1, Slightly
loose feces; 2, Loose feces; 3, Watery diarrhea) and a 0–3 scale (0, Normal; 1, Slightly bloody; 2, Bloody; 3, Blood in the whole colon), respectively, in K2P5.1
+/+ and
K2P5.1
−/− mice. (C) spleen weights relative to body weights in K2P5.1
+/+ and K2P5.1
−/− mice. (D) the colon weight/length ratio was measured in K2P5.1
+/+ and
K2P5.1
−/− mice. (E–G) Photographs of colon sections from K2P5.1
+/+ and K2P5.1
−/− mice with H&E staining (magnification, X100) (E). Scale bar, 100µm.
Colonic inflammation (F) and crypt damage (G) were assessed histologically. (H) Expression of K2P5.1 transcripts relative to ACTB transcripts in CD4
+CD25− and
CD4+CD25+ subsets from K2P5.1
−/− mice. (I) summarized data are shown as alkaline pHe (pHe 8.5)-induced hyperpolarizing responses in the splenic CD4+ T
cells of control and IBD model mice. Results were expressed as means ± SEM. The numbers used for the experiments are shown in parentheses. *, **P < 0.05, 0.01
vs. K2P5.1
+/+ (D).
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DISCUSSION
The activation of K+ channels in T cells promotes Ca2+ influx,
thereby indirectly modulating Ca2+ signaling (Vig and Kinet,
2009). Two K+ channel subtypes, the voltage-gated KV1.3 and
intermediate-conductance Ca2+-activated K+ channel KCa3.1,
are known to mainly function in T and B lymphocytes (Di
Sabatino et al., 2009). The physiological role of the two-pore
domain K+ channel K2P5.1 was recently clarified in lymphocytes
(Nam et al., 2011; Cid et al., 2013; Shin et al., 2014), and
several studies have shown the pathophysiological impact of
the upregulation of the two-pore domain K+ channel K2P5.1
in CD4+ T cells on the pathogenesis of autoimmune diseases
such as rheumatoid arthritis and multiple sclerosis (Bittner et al.,
2010a, 2011). However, the pathophysiological impact of K2P5.1
in diseases associated with Th1 and Th17 cytokine profiles has
not yet been examined using in vivo animal models. This is
the first study to employ chemically-induced IBD model mice
to characterize the pathophysiological role of K2P5.1 in mature
CD4+ T cells. The main results of the present study were as
follows: (1) Facilitation of the expression level and functional
activity of the K2P5.1 K
+ channel in splenic CD4+ T cells of IBD
model mice, especially in the CD4+CD25− subset (Figures 1, 2),
(2) Decreased disease activity index (diarrhea, bloody feces, and
weight loss) and histopathological scores (colonic inflammation
and crypt damage) in homozygous K2P5.1-deficient (K2P5.1
−/−)
mice (Figure 4). We were unable to elucidate the mechanism
underlying the transcription regulation of K2P5.1 in the splenic
CD4+ T cells of IBD model mice. The voltage-gated K+ channel
KV1.3 and Ca
2+-activated K+ channel KCa3.1 are the main K
+
conductance channels in CD4+ T cells. Although both transcripts
were expressed in splenic CD4+CD25− cells at high levels, no
significant differences were observed in their expression levels
between control and IBD model mice (not shown). These results
suggested that the upregulation of K2P5.1 played an important
role in the changes observed in T cell Ca2+ signaling in IBD
pathogenesis, and may affect the facilitation of proliferation and
infiltration of splenic CD4+ T cells. K2P5.1 also contributes to
the regulation of osmotic volume, regulatory volume decreases
(RVD), in several types of cells including T cells (Niemeyer et al.,
2001; Bobak et al., 2011; Andronic et al., 2013), which participate
in cell cycle progression. Therefore, a dysfunction in cellular
volume homeostasis via the upregulation of K2P5.1 may also be
involved in dysregulated cellular functions in the CD4+ T cells of
IBD model mice.
As shown in Figure 3A, the upregulation of K2P5.1 was
greater in splenic CD4+CD25− T cells of IBD model mice
than in CD4+CD25+ T cells. CD4+CD25− T cells include
pro-inflammatory Th1 and Th17 subsets, and an increase was
observed in the transcription of IFN-γ and IL-17A in the splenic
CD4+CD25− T cells of IBD model mice (Figures 3B,C). Due
to the lack of a selective K2P5.1 inhibitor, we were unable
to examine the effects of its in vivo administration on the
disease activity index and histopathological scores in IBD model
mice in order to clarify the pathophysiological significance
of K2P5.1 in IBD. However, we showed that the genetic
knockdown of K2P5.1 significantly protected against IBD via the
FIGURE 5 | Expression levels of IFN-γ and IL-17A transcripts in
CD4+CD25− subset of IBD models from K2P5.1
+/+ (+/+) and
K2P5.1
−/− (-/-) mice (A,B), and IL-10 transcripts CD4+CD25+ subset
of IBD models from K2P5.1
+/+ (+/+) and K2P5.1
−/− mice (-/-) (C).
Expression levels were measured using a real-time PCR assay. Results were
expressed as means ± SE. Numbers used for the experiments are shown in
parentheses. *P < 0.01 vs. K2P5.1
+/+ mice.
amelioration of severe colitis and colonic inflammation using
homozygous K2P5.1 knockdown K2P5.1
−/− mice (Figure 4).
Furthermore, the expression levels of the IFN-γ transcripts from
the pro-inflammatory Th1 subset were significantly lower in the
CD4+CD25− cells of the IBD model from K2P5.1
−/− mice than
from K2P5.1
+/+ mice (Figure 5A), and no significant differences
were noted in the expression levels of IL-17 in CD4+CD25−
cells and IL-10 in CD4+CD25+ cells between IBD models from
K2P5.1
+/+ and K2P5.1
−/− mice (Figures 5B,C). Similar findings
were obtained with the genetic and pharmacological knockdown
of the Ca2+-activated K+ channel KCa3.1 in an IBD model (Di
et al., 2010; Ohya et al., 2014; Ohya and Imaizumi, 2014). It
has been reported that the function of Th1 was impaired in
an IBD model from KCa3.1
−/− mice, whereas that of Th17
was normal (Di et al., 2010). We recently demonstrated the
inhibition of IFN-γ transcription, but not that of IL-17A by
the in vivo administration of selective KCa3.1 inhibitors in a
DSS-induced IBD model (Ohya et al., 2014). Therefore, the
development of small molecule K2P5.1 modulators may represent
therapeutic and/or preventative strategies for the treatment of
inflammatory and autoimmune disorders and cancer, and the
establishment of a novel high-throughput screening system to
detect these modulators currently required (Bagriantsev et al.,
2013). Furthermore, novel findings on the regulatory molecules
of K2P5.1 will provide insights into the inhibition of K2P5.1.
Regulatory T (Treg) cells play an important role in the
maintenance of intestinal homeostasis, and Treg cells are
considered to be beneficial for IBD therapy (Boden and Snapper,
2008; Himmel et al., 2012; Gibson et al., 2013; Mayne and
Williams, 2013). As shown in Figure 3A, the expression levels
of K2P5.1 transcripts of K2P5.1 were significantly increased in
the splenic CD4+CD25+ T cells of IBD model mice. This
subset also included Foxp3-positive cells (not shown) and, thus,
is referred to as naturally-occurring regulatory T cells. In B
lymphocytes, the production of the anti-inflammatory cytokine
IL-10 was shown to be stimulated by Ca2+ influx via the CRAC
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channel (Matsumoto et al., 2011; Baba et al., 2014). Therefore,
the upregulation of K2P5.1 may strengthen the production of
IL-10 in the natural Treg cells of IBD model mice, and the
activation of K2P5.1 may improve the pathogenesis of IBD.
In the present study, the expression of IL-10 was significantly
higher in the natural Treg cells of IBD model mice than in
those of control mice (Figure 3E). No significant changes in
the expression of IL-10 were found in natural Treg cells of the
IBD model from K2P5.1
−/− mice (Figure 5C); however, the
long-lasting dysregulation of Ca2+ signaling elicited by a K2P5.1
deficiency may be compensated by the upregulation of other K+
channel(s), and, thus, the expression of IL-10 may be maintained
within normal ranges in the Treg cells of the IBD model from
K2P5.1
−/−mice. Further studies are needed in order to clarify the
pathophysiological role of K2P5.1 in the natural Treg cells of IBD.
In conclusion, the results of the present study suggested that
the background K+ channel K2P5.1 in splenic CD4
+ T cells was
involved in the pathogenesis of IBD using a chemically-induced
IBD model and provided evidence for the K2P5.1 K
+ channel
as a potential therapeutic target for suppressing the progression
of IBD. Dysregulated K2P5.1 may stimulate the Th1 imbalance
in the process of intestinal inflammation. The lack of selective
K2P5.1 blockers may facilitate future research on a novel high-
throughput screening system to detect small molecule K2P5.1
modulators and the regulatory mechanisms underlying K2P5.1
transcription, translation, and protein degradation in IBD.
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